Investors

Home » investors » Corporate Information » Corporate Profile

Corporate Profile



Investor Tools

  • Email page
  • PDF view
  • Print view
  • Email Alert
  • RSS Feeds
  • Mobile IR Site
  • Social Media Sharing
  • Email page
  • PDF view
  • Print view
  • Email Alert
  • RSS Feeds
  • Mobile IR Site
  • Social Media Sharing

Stock Quote

  • NASDAQFBIO
  • Market Value ($M)109.58
  • Change ($)(0.02)
  • Change (%)(0.88)
  • Volume142,973
  • Stock Quote ($)2.25
As of January 20, 2017 - Minimum 20 minute delay.

Fortress Biotech, Inc. (“Fortress”) is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies, also known as Fortress Companies. Additionally, Fortress recently acquired a controlling interest in National Holdings Corporation (NASDAQ: NHLD), a diversified independent brokerage company (together with its subsidiaries, “NHLD”). In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies achieve their goals. Fortress and the Fortress Companies may seek licensings, acquisitions, partnerships, joint ventures and/or public and private financings to accelerate and provide additional funding to support their research and development programs.

Contact Information

Fortress Biotech, Inc.
2 Gansevoort Street
9th Floor
New York, NY 10014
info@fortressbiotech.com

Investor Relations
Lucy Lu, M.D., EVP & CFO
ir@fortressbiotech.com
(781) 652-4500



All Releases